title: Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis.
abstract: BACKGROUND
  The aim of this study was to inform an evidence-based management policy for oral dysplastic lesions.
  
  
  METHODS
  Systematic review was performed with meta-analysis. Studies reporting follow-up of patients with histologically confirmed oral dysplasia were included. Outcome measures included malignant transformation rate (MTR) and time to malignant transformation (TMT). Subgroup analysis was performed by histologic grade, clinical risk factors, and treatment modality. Heterogeneity was assessed.
  
  
  RESULTS
  Fourteen nonrandomized studies, reporting on 992 patients, were included. There was considerable heterogeneity between studies: mean overall MTR = 12.1% (confidence interval: 8.1%, 17.9%) and mean TMT = 4.3 years. Histologic grade significantly affected mean MTR (p < .008). Lesions that were not excised demonstrated considerably higher MTR than those that were excised (p = .003).
  
  
  CONCLUSIONS
  Oral dysplasia showed a significant rate of transformation to cancer, which was related to grade and was decreased significantly but not eliminated by excision. This suggested the need for excision and continued surveillance.
authors.affiliation: Department of Head and Neck Surgery, Institute of Head and Neck Studies and Education, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom. hisham.mehanna@uhcw.nhs.uk
authors.forename: Hisham M
authors.initials: HM
authors.lastname: Mehanna
authors.forename: Tim
authors.initials: T
authors.lastname: Rattay
authors.forename: Joel
authors.initials: J
authors.lastname: Smith
authors.forename: Christopher C
authors.initials: CC
authors.lastname: McConkey
mesh_terms: D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006965:Hyperplasia / Q000473:pathology; D015994:Incidence; D008297:Male; D009055:Mouth / Q000473:pathology*; D009059:Mouth Diseases / Q000473:pathology / Q000628:therapy; D009062:Mouth Neoplasms / Q000453:epidemiology / Q000473:pathology* / Q000601:surgery / Q000628:therapy; D011230:Precancerous Conditions / Q000473:pathology* / Q000601:surgery* / Q000628:therapy; D018570:Risk Assessment